Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Wonder uses AI to power everything from recommendations to logistics — yet, as of now, reported CTO James Chen, AI adds just a few cents per order. Chen explained that the technology component of a ...
Ultrasound examination has become a key tool in clinical diagnosis due to its safety, non-invasiveness, lack of ionizing radiation, and ease of use. However, traditional ultrasound imaging faces a ...
Shenzhen, May 14, 2025 (GLOBE NEWSWIRE) -- MicroAlgo Inc. (MLGO) Announces Research on Quantum Information Recursive Optimization (QIRO) Algorithm, for Combinatorial Optimization Problems to Expand ...
MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.
Consumer health and wellness is experiencing a flurry of activity. Meanwhile, Oura competitor Whoop, maker of a smart band, just announced the latest versions of its device, with the ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback